For instance, in cervical cancer, methylation of the Casp8A2 gene is sufficient to increase drug resistance; on the contrary, hypermethylation of WRN confers cervical cancer cells high sensitivity to the topoisomerase I inhibitor (CPT-11) (47). This evidence concerns the gene WRN and cervical carcinoma.